Submitted by Anonymous (not verified) on 20 October 2026 - 11:48
Human medicines European public assessment report (EPAR): Polivy, polatuzumab vedotin, Date of authorisation: 16/01/2020, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Polivy, polatuzumab vedotin, Date of authorisation: 16/01/2020, Revision: 9, Status: Authorised